STABLE Score (TEVAR Risk) Calculator

Clinical calculation support · Verify results before clinical use

Risk factor assessment

Select each finding present at presentation. Each selected factor contributes one point to the unweighted total.

0Score / 4
1

Shock on presentation

Shock documented at initial clinical presentation.

+1 point
2

Malperfusion

Clinical or imaging evidence of organ or limb malperfusion.

+1 point
3

Age greater than 70 years

Use the threshold as written in the supplied source code; confirm the threshold against the original model before clinical use.

+1 point
4

Previous aortic surgery

History of prior aortic surgery.

+1 point
0Total score
Calculated unweighted total
0 of 4 factors selected
A validated mortality probability cannot be displayed from the evidence currently verified for this tool.
Clinical interpretationThis is a simple sum of the four factors listed in the supplied code, not a verified probability estimate. Do not use it alone to determine procedural candidacy or management.

The score total is a mathematical calculation only. The risk categories and 30-day mortality percentages in the original code have not been independently verified against an identifiable primary publication.

About this assessment

The supplied template describes a four-factor assessment intended to estimate 30-day mortality after thoracic endovascular aortic repair (TEVAR) for complicated type B aortic dissection. The implementation adds one point for each selected factor, producing a possible total of 0–4.

Important evidence limitation: the supplied citation, “Pape LA, et al. The STABLE Score: A Risk Model for 30-Day Mortality After TEVAR in Acute Type B Aortic Dissection,” with DOI 10.1016/j.jtcvs.2018.09.054, could not be verified as a matching publication in the search performed for this revision. The label “STABLE Score” may be confused with the STABLE endovascular device studies, which are not themselves evidence that this four-variable prediction score is validated.

Factors entered

FactorScoring in this tool
Shock on presentation1 if present; otherwise 0
Malperfusion1 if present; otherwise 0
Age >70 years1 if present; otherwise 0
Previous aortic surgery1 if present; otherwise 0

Interpretation and limitations

No low-, intermediate-, or high-risk mortality strata are shown because the percentages in the original code could not be substantiated from the cited source. Before describing this as a validated prediction model, confirm the original publication, exact predictor definitions, derivation population, calibration, discrimination, and external validation.

References and evidence notes

Supplied reference requiring verification Pape LA, et al. “The STABLE Score: A Risk Model for 30-Day Mortality After TEVAR in Acute Type B Aortic Dissection.” The supplied title and DOI could not be matched during this search. Do not cite as verified until checked against the publisher or PubMed record.
STABLE II clinical trial Hughes GC, et al. STABLE II clinical trial on endovascular treatment of acute, complicated type B aortic dissection with a composite device design. J Vasc Surg. 2019. This evaluates a device/treatment study, not validation of the four-factor score. PubMed record.
TEVAR outcomes in type B dissection Thirty-day outcomes from the Society for Vascular Surgery Vascular Quality Initiative thoracic endovascular aortic repair for type B dissection project. J Vasc Surg. 2019. Relevant clinical outcomes context, not confirmation of this score. Publisher DOI.
Clinical disclaimer: This page currently calculates only the arithmetic sum of four user-selected factors. It does not provide a validated estimate of 30-day mortality. Use clinical judgement, current aortic disease guidance, patient-specific anatomy and physiology, and multidisciplinary aortic-team assessment for decisions. Verify the model's original source before clinical deployment.